Therapeutic Targeting of CLDN1 Reduces Glomerular Crescent Formation and Fibrosis and Preserves Renal Function in ANCA-Associated Glomerulonephritis

lixudebart (ALE.F02) - Alentis Therap

https://www.asn-online.org/education/kidneyweek/2025/program-abstract.aspx?controlId=4345597

Geoffrey Teixeira; Minh Huan Dang; Peemapat Prakongtham; Chunni Lu; Elisa Polini; Isabelle Chanemouga; Silvia Cavadini; Vincent Anquetil; Corentin Herbert; Roberto Iacone; A. Richard Kitching

Oct 18, 2025